2024 Prostate Cancer Patients & Caregivers Virtual Conference
WATCH THE REPLAY BELOW | FILMED IN-PERSON IN LA
The 2024 Prostate Cancer Patients & Caregivers Virtual Conference, originally filmed in Los Angeles at our in-person conference, will air for free on PCRI.org on October 20, 2024. This is a great opportunity for prostate cancer patients to hear the latest updates from leading experts, covering treatments, side effects, imaging advancements, and more—all from the comfort of home. Don't miss out on this valuable event!
DEDICATED TO TOM KIRK
The upcoming conference is dedicated to the memory of Thomas Kirk, a devoted leader in the fight against prostate cancer.
Tom's remarkable legacy, spanning his work with prostate cancer non-profits, Us TOO International and the National Alliance of State Prostate Cancer Coalitions, continues to inspire and guide our efforts today.
AGENDA
SUNDAY, OCTOBER 20, 2024
8:00am - 8:10am / Opening Remarks / Alex Scholz & Mark Moyad, MD
8:10am - 9:25am / Advanced Treatments & Side Effects / Elisabeth Heath, MD
9:25am - 10:40am / Active Surveillance / Laurence Klotz, MD
10:40am - 11:05am / Tom Kirk Memorial Dedication & Award Ceremonies: The Harry Pinchot Awarded to Terri Likowski & The Bob Each Awarded to Jan Manarite
11:05am - 12:20pm / Radiation & Side Effects / Mack Roach III, MD
12:20pm - 1:35pm / Prostate Imaging / Daniel Margolis, MD
1:35pm - 2:50pm / Incontinence & Sexual Side Effect Treatments / Jeffrey Brady, MD
2:50pm - 5:00pm / 2024 Conference Review & Extended Q+A / Mark Moyad, MD, MPH & Mark Scholz, MD
*Agenda subject to change
EXHIBIT HALL
Bayer is a global life sciences leader in healthcare and nutrition. Building on a 150-year legacy in healthcare, Bayer is committed to improving patient lives by developing therapies and delivering first-in-class educational and support programs to meet their needs.
This information has been reviewed according to the US law and is consistent with US Prescribing Information and is intended for US audience only. Prescribing Information may vary depending on local approval in each country.
Click here to learn more about Xofigo (radium Ra 223 dichloride)
Click here to learn more about NUBEQA (darolutamide)
For additional information, contact:
Rebecca Cowens-Alvarado, MPH
Deputy Director Advocacy Relations
Erleada
Prescribing Information:
Financial Resources:
Paying for ERLEADA:
https://www.erleada.com/paying-for-erleada
Know Your State Interactive Tool:
https://www.janssencarepath.com/sites/www.janssencarepath-v1.com/files/know-your-state.pdf
EDUCATIONAL RESOURCES
Living With Cancer Website:
https://www.thisislivingwithcancer.com/living-with-app
Pfizer Virtual Booth:
http://pfizeroncologycongressresources.com
Living With Cancer iTunes App:
https://apps.apple.com/us/app/id1223073769
Know Your Prostate Plan – Patient Videos
Click here for Full Prescribing Information
PROVENGE
Prescribing Information:
https://www.provengehcp.com/Portals/5/Provenge-PI.pdf
Other Resources:
Provenge Support Information
https://www.provenge.com/Support
Your Provenge Experience:
POSLUMA
https://www.posluma.com/patient/
Patient Brochure:
https://www.posluma.com/patient-brochure.pdf
Learn more about Blue Earth & Prostate Cancer:
Blue Earth Diagnostics Prostate Cancer (prostatecancer-blueearthdx.com)
CLICK HERE TO DOWNLOAD THE BROCHURE
PROSTOX genetic tests help prostate cancer patients choose the safest form of radiation treatment
These tests predict a patient’s risk of late, long-term side effects following two radiation treatment approaches for prostate cancer, based on the number of fractions a patient will receive:
PROSTOX ultra: for 5-7 fractions (sessions) given over 10 days, and called stereotactic body radiotherapy (SBRT)
PROSTOX CFRT: for 35-45 fractions (sessions) given over 8-10 weeks
Patient Information and Access
Find out if you’re eligible to access PROSTOX testing through MiraKind and learn more: https://mirakind.org/prostox-testing/
Clinical evidence and Information for physicians
Prolaris Explainer Video
Gary’s Prolaris Patient Testimonial
FoundationOne CDx
Patient Report Guide:
FoundationOne LiquidCDx
Patient Report Guide:
Patient Brochure:
https://www.foundationmedicine.com/sites/default/files/document/Patient_Booklet.pdf
PAN FOUNDATION
We help underinsured people with life-threatening, chronic and rare diseases get the medications and treatments they need by assisting with their out-of-pocket costs and advocating for improved access and affordability.
RESOURCES:
The PAN Foundation: https://www.panfoundation.org/
Our disease funds: https://www.panfoundation.org/find-disease-fund/
Find patient assistance in minutes! Sign up for FundFinder: https://fundfinder.panfoundation.org/
Become an advocate: https://www.panfoundation.org/become-an-advocate/
OUR SPEAKERS
Elizabeth Heath, MD - Advanced Treatments & Side Effects
Dr. Heath is the Associate Center Director of Translational Sciences, leads the Genitourinary Oncology Multidisciplinary Team at the Karmanos Cancer Institute and is a professor of Oncology at Wayne State University School of Medicine. She leads groundbreaking research in prostate cancer, with a focus on addressing health disparities in clinical trials. A respected leader in her field, Dr. Heath has received numerous awards and serves on several national committees dedicated to cancer research. Read More
Mack Roach III, MD - Radiation Treatments and Side Effects
Dr. Roach is a Professor of Radiation Oncology and Urology at the University of California, San Francisco, and is widely recognized as a leading authority on localized prostate cancer treatment. His research focuses on the use of advanced radiation therapies, such as image-guided IMRT and Brachytherapy, to optimize treatment outcomes while minimizing side effects. Dr. Roach has published over 200 peer-reviewed articles and was appointed by President Obama to the National Cancer Advisory Board. Read More
Daniel Margolis, MD - Prostate Imaging
Dr. Margolis is a Professor of Radiology specializing in Abdominal Imaging and leads clinical efforts in using prostate MRI for cancer detection, treatment planning, and follow-up, contributing to numerous publications demonstrating its effectiveness. Dr. Margolis is a member of the American College of Radiology’s Prostate Imaging Reporting and Data Systems steering committee and has lectured at prestigious conferences worldwide. Fluent in Spanish and Swedish, Dr. Margolis has authored more than 100 publications. Read More
Laurence Klotz, MD - Active Surveillance
Dr. Laurence Klotz is a Professor of Surgery at the University of Toronto and holds the Sunnybrook Chair of Prostate Cancer Research. He is the Founder and Chairman of the Canadian Urology Research Consortium and the Chair of the Global GU Oncology Group. With over 350 publications and several books, Dr. Klotz is a widely respected uro-oncologist whose main research focus is prostate cancer. He has served on numerous medical boards and editorial committees, and his contributions to the field have earned him many prestigious awards. Read More
Jeffrey Brady, MD - Incontinence & Sexual Side Effect Treatments
Dr. Jeff D. Brady, MD, FACS, is a board-certified urologist with over 20 years of experience, specializing in reconstructive urology since 2021. Known for his advanced training and expertise, Dr. Brady is a trusted resource for managing complex urologic conditions in both adults and children. His practice offers both surgical and nonsurgical treatments for issues such as erectile dysfunction, male urinary incontinence, Peyronie’s disease, urethral stricture disease, and congenital urologic abnormalities. Dr. Brady is also skilled in managing complications from prostate and pelvic cancer treatments. Read More
Mark Moyad, MD - Moderator & Extended Q&A
Dr. Mark A. Moyad, MD, MPH, is the Jenkins/Pokempner Director of Complementary and Alternative Medicine (CAM) Education at the University of Michigan Medical Center. With a career spanning more than 25 years, Dr. Moyad is dedicated to promoting comprehensive lifestyle changes to enhance mental, physical, and spiritual wellness. He is a recognized expert in clinical epidemiology and public health education, with a focus on dietary supplements and other health options. Dr. Moyad has authored over 150 medical journal articles and 15 books, and he has lectured extensively to health care professionals and the public worldwide. Read More
Mark Scholz, MD - Host & Extended Q&A
Dr. Mark C. Scholz, MD, is a double board-certified medical oncologist and the executive director of the Prostate Cancer Research Institute (PCRI). He also serves as the medical director of Prostate Oncology Specialists Inc. in Marina del Rey, CA, a practice dedicated exclusively to prostate cancer.
He is the co-author of Invasion of the Prostate Snatchers and the author of The Key to Prostate Cancer. As co-founder of PCRI, he is involved in groundbreaking research and clinical trials focused on improving prostate cancer treatment and patient outcomes. Dr. Scholz has published over 90 scholarly articles and continues to be an influential figure in the field of oncology. Read More
OUR SPONSORS
Gold
Silver
Bronze
Our Advocacy Partners
A special thank you to all of our incredible advocacy partners!
We encourage all prostate cancer patients and their care-partners to explore the incredible resources provided by the other advocacy groups we've listed below. These organizations offer invaluable support, information, and community that can make a significant difference in your journey. The Prostate Cancer Research Institute deeply appreciates the remarkable work of these groups and extends our heartfelt thanks to them for their dedication and contributions. Your involvement with these groups can provide additional strength and guidance, enhancing your path to better health.
